Gerry Melino
Impact in
- Cancer Research top 0.05%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Oncology top 0.05%
- Cancer-related Molecular Pathways
Papers in
- Oncology 238
- Cancer-related Molecular Pathways 193
- Cancer Research 114
- Cancer, Hypoxia, and Metabolism 44
- Co-authors
- Eleonora CandiIvano AmelioRichard A. KnightVincenzo De LaurenziFrancesca BernassolaMassimiliano AgostiniMargherita Annicchiarico‐PetruzzelliRainer Schmidt
- Journals
- Biochemical and Biophysical Research Communications (45 papers)Cell Death and Differentiation (39 papers)Oncogene (38 papers)Cell Death and Disease (38 papers)Proceedings of the National Academy of Sciences (34 papers)
- Partner nations
- ItalyUnited KingdomUnited States
In The Last Decade
Gerry Melino
611 papers receiving 36.4k citations
Hit Papers
Peers
Comparison fields: 5 of 186
- Cancer Research 7.1k
- Oncology 11.0k
- Biotechnology 2.8k
- Molecular Biology 22.1k
- Cell Biology 3.8k
Countries citing papers authored by Gerry Melino
This map shows the geographic impact of Gerry Melino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerry Melino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerry Melino more than expected).
Fields of papers citing papers by Gerry Melino
This network shows the impact of papers produced by Gerry Melino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerry Melino. The network helps show where Gerry Melino may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerry Melino, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 17 | |
| 6 | 2023 | 17 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 21 | |
| 9 | 2021 | 16 | |
| 10 | 2021 | 11 | |
| 11 | 2021 | 16 | |
| 12 | 2021 | 35 | |
| 13 | 2020 | 46 | |
| 14 | 2020 | 24 | |
| 15 | 2019 | 3 | |
| 16 | 2018 | 46 | |
| 17 | 2011 | 126 | |
| 18 | 2008 | 17 | |
| 19 | 2006 | 104 | |
| 20 | 2006 | 50 |
About Gerry Melino
Gerry Melino is a scholar working on Oncology, Cancer Research, Biotechnology, Molecular Biology and Cell Biology, having authored 625 papers that have together received 36.9k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (193 papers), Ubiquitin and proteasome pathways (61 papers), Blood properties and coagulation (60 papers), Epigenetics and DNA Methylation (57 papers), Cancer Research and Treatments (57 papers), Cell death mechanisms and regulation (52 papers), RNA modifications and cancer (50 papers) and Cancer, Hypoxia, and Metabolism (44 papers). The work is most often cited by research in Cancer Research (7.1k citations), Oncology (11.0k citations), Biotechnology (2.8k citations), Molecular Biology (22.1k citations) and Cell Biology (3.8k citations). Gerry Melino has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Eleonora Candi, Ivano Amelio, Richard A. Knight, Vincenzo De Laurenzi, Francesca Bernassola, Massimiliano Agostini, Margherita Annicchiarico‐Petruzzelli, Rainer Schmidt, Mauro Piacentini and Alessandro Terrinoni. Their work appears in journals such as Biochemical and Biophysical Research Communications, Cell Death and Differentiation, Oncogene, Cell Death and Disease and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.